background: Retinoblastoma (RB) is the most frequent eye tumour in children, with an incidence of 1 in 15 -20 000 births. It accounts for 11% of all cancers in the first year of life. Except for the hereditary forms, its causes are not well-known. Studies have recently suggested an increased risk of RB among children born after IVF, but the relevant literature is sparse. We assessed the association between infertility treatment, subfertility and RB. results: The study included 244 non-familial RB cases. The risk of RB increased with maternal age [adjusted odds ratio (adj OR) ¼ 2.07, 95% confidence interval (CI) 1.33-3.22 at 35-39 years compared with younger than 25 years and adj OR ¼ 2.42, 95% CI 1.22 -4.81 at 40 years or older], but the associations with IVF (adj OR ¼ 1.37, 95% CI 0.64 -2.95) and ovarian stimulation or intrauterine insemination (adj OR ¼ 1.35, 95% CI 0.77 -2.38) were not statistically significant after adjustment for maternal age and tobacco use. Among women who had no infertility treatment, the risk of RB was significantly increased when time to pregnancy exceeded 24 months (adj OR ¼ 2.02, 95% CI 1.17 -3.48) compared with time to pregnancy ≤24 months.
Introduction
Retinoblastoma (RB) is a malignant tumour of the retina that occurs in childhood. The incidence of this disease is approximately 1 in 15-20 000 children. It accounts for 11% of all cancers in the first year of life. Overall, 65% of RBs are diagnosed before the age of 2 years and 95% before 5 years (Abramson and Schefler, 2004; Doz et al., 2004) . This tumour affects boys and girls indiscriminately. Even though the prognosis for children is generally good in industrialized countries, with .95% of those diagnosed alive 5 years later (Aerts et al., 2006) , this cancer, its treatment and its functional and psychological impact leave severe scars on children and their families.
Most cases of RB are sporadic. In 10 -15% of RB cases, there is a familial history. The distribution of cases within the family is compatible with a genetic predisposition transmitted according to an autosomal dominant mode with high penetrance.
Among sporadic cases, 70% present a unilateral tumour and 30% a bilateral tumour. Both familial and sporadic bilateral cases carry a germline monoallelic RB1 mutation. In addition, 10% of sporadic unilateral cases also carry a germline mutation. This germline mutation is transmitted by a parent in familial cases and occurred at a pre-or post-zygotic level in sporadic cases. In most sporadic unilateral RB cases, a late-onset RB1 mutation occurs at a somatic level in retina cells.
The risk factors highlighted in the literature are older maternal age (Moll et al., 1996; Yip et al., 2006) and, less consistently, infectious or environmental risk factors (Orjuela et al., 2000 (Orjuela et al., , 2005 . The risk of RB in children born after assisted reproductive technology (ART) in general and IVF in particular has been in question since Anteby et al. (2001) reported a case of RB in a child born after IVF. Subsequent studies have shown mixed results. In 2003, a Dutch study looked at a population-based RB registry and found an increased risk of RB among children born after IVF (Moll et al., 2003) . More recently, the same group (Marees et al., 2009) On the other hand, population-based studies have examined RB among children conceived after IVF in the UK (Bradbury and Jick, 2004) and in Denmark (Lidegaard et al., 2005) . Neither found an elevated risk of this cancer. Some findings have induced concerns about higher cancer rates in general after IVF (Kallen et al., 2010) , but the results remain limited.
Nevertheless, some authors have suggested that ART children might have imprinting disorders (Niemitz and Feinberg, 2004; Sutcliffe et al., 2006) . These publications underline the crucial role of epigenetic modifications in the control of gene expression. The difficulty, however, arises in determining whether they are primarily due to the treatment (and if so, to which part thereof), to maternal characteristics, or to the underlying cause of parental infertility or subfertility which could be explored by indirect factors such as time to pregnancy.
In France, as elsewhere, the development of ART has dramatically changed the treatment of infertility. IVF and its related procedures, including ICSI and frozen embryo transfer, have become common (FIVNAT, 1997) . Over the past 30 years, 200 000 children have been born after IVF. Although less is known about the number of children born after induction of ovulation and intrauterine insemination, it is estimated that 40 000 children, 5% of the births in France, are born annually after ART, 15 000 of them after IVF (de la Rochebrochard, 2008) .
The objective of our study was to test the existence of an association between RB and infertility treatments or time to pregnancy.
Materials and Methods

Population
The study included all children living in France (excluding French overseas territories) diagnosed with RB between 1 January 2000 and 31 December 2006 at the Institut Curie, the French reference centre for both the diagnosis and treatment of RB, where most children with this disease are treated.
The Comité Consultatif sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé (CCTIRS, committee for health-related data treatment) and the Commission Nationale de l'Informatique et des Libertés (CNIL, French Data Protection Authority) both approved the study, as required by French law. The medical team at the Institut Curie described the study to parents and provided them with written information. In accordance with French regulations, written consent was not collected, but parents who declined to participate could submit a refusal form.
Data on mothers' characteristics (age, parity, nationality, marital status, smoking status and educational level) were collected in a questionnaire sent to the families between 2007 and 2008. The questionnaire also included questions on paternal age and on the existence and type of infertility treatment (IVF, IUI, ovarian stimulation) used to obtain the pregnancy in question. Time to pregnancy was collected for spontaneous pregnancies. Data on obstetric history, prenatal care, delivery and the child's health status at birth were also collected. Data on RB (type, side) were extracted from hospital medical records.
We excluded familial forms. Among non-familial forms of RB, we made a distinction between multifocal (bilateral or unilateral multifocal) and unilateral unifocal forms. We considered that genetic mutations were present in all multifocal forms. Unilateral unifocal cases for which we had a genetic analysis were classified according to the result (genetic mutation identified or not).
We limited the study to children with non-familial forms of RB living in France at the time of diagnosis (so that we could follow them over time) and born in France (to ensure comparability with the reference group). The inclusions were limited to children aged 5 years or less at diagnosis to optimize the assessment of their perinatal history and reduce memory bias about infertility treatment as much as possible. The reference group was the French National Perinatal Survey representative birth samples from 1998 to 2003 (Blondel et al., 2011) , including 29 173 live births. Data on maternal, social and demographic characteristics and antenatal care came from post-delivery interviews of the mothers, and data on the children's health at birth from hospital records. Missing information on infertility treatment for 1403 children left 28 170 children available for comparison. Time to pregnancy was available only in the 2003 survey, i.e. 12 642 births.
Statistical analysis
Responders and non-responders were first compared for the following characteristics: maternal age at birth, type of pregnancy (singleton or multiple), infant's sex, mean age at diagnosis and RB type.
The following groups of RB were compared with the reference group: first all non-familial forms together, then bilateral or unilateral multifocal forms and unilateral unifocal forms separately and finally unilateral unifocal forms without any identified genetic mutation.
Comparisons of the following characteristics were made: mother's age at birth, parity, type of pregnancy, smoking status, marital status, nationality, educational level, father's age at birth, infertility treatment and time to pregnancy.
Maternal and paternal ages were considered in five categories (,25, 25 -29, 30 -34, 35-39 and ≥40 years) . Maternal smoking status, a known risk factor of infertility, was categorized as follows: non-smoker, smoker before pregnancy but stopped during pregnancy or smoker before and during the pregnancy. Educational level was classified into three levels: university (or equivalent), higher secondary education and elementary school or lower secondary education. Infertility treatments were first studied together (treatment versus no treatment), and then categorized in three groups: IVF, IUI and ovarian stimulation alone. The IVF category included IVF and related techniques [ICSI, gamete intraFallopian transfer and transfer of frozen embryos]. For families with no infertility treatment, time to pregnancy was categorized as ≤24 months, .24 months or unplanned pregnancy. We chose the 24-month cut-off period because it is a widely used reference point for defining severe subfertility (Evers, 2002) .
We further analysed the association between infertility treatment and RB, taking maternal age and smoking status into account in logistic regression models. In addition, we studied the risk of RB according to time to pregnancy among women without infertility treatment, also taking these maternal characteristics into account.
Two additional analyses were conducted. The first controlled for maternal educational level, to take into account the higher rate of use of infertility treatment in higher social groups. The second considered women with missing data about infertility treatment in the national reference sample as untreated, to verify that we did not overestimate the difference in treatment with the RB cases.
All statistical tests were two-sided, with P-values ,0.05 considered significant. In each model, we estimated the adjusted odds ratios (adj ORs) and the corresponding confidence intervals (95% CI), using SAS software.
Results
Between 1 January 2000 and 31 December 2006, the Institut Curie diagnosed 427 children with RB; 98 were excluded because they did not live in France at the time of diagnosis, 11 because they were older than 5 years, 3 because they died and 2 because they had only visited the Institut Curie for a second opinion or a relapse.
Among the 313 eligible children, 31 had familial and 282 non-familial forms. Among the latter, 259 completed the questionnaire (a 92% response rate); 14 of them were excluded because they were born outside France and one because of missing data on infertility treatment. Therefore, the analysis finally included 244 cases of non-familial RB (Fig. 1) , with 88 cases of bilateral or multifocal forms, 156 cases of unilateral unifocal forms including 113 unilateral unifocal forms without genetic mutation identified.
The non-respondents did not differ from respondents for maternal age, type of pregnancy, child's sex, age at diagnosis, type of RB or genetic mutation (Table I) .
Mothers of children with RB were significantly older than those in the reference group; 25% were 35 years or older compared with 15% in the reference population (Table II) . They were also significantly more likely to smoke (46 versus 39%). There was no significant difference for parity, type of pregnancy, marital status, nationality, educational level or paternal age at birth. Of the 20 mothers of RB cases who had undergone infertility treatment, 2 had IVF, 5 ICSI, 2 IUI (1 with donor) and 11 had ovarian stimulation only. Neither the rates nor types of infertility treatments differed statistically between the cases and the reference population (Table III) . However, in all the nonfamilial forms, time to pregnancy was higher, exceeding 24 months in almost 7% compared with 3% in the reference population. The trend was the same for the unilateral unifocal RB subgroup, although not statistically significant for the cases without identified mutation (results not shown).
After adjusting for maternal age and smoking (Table IV) , the risk of RB associated with infertility treatment was not significantly increased. The adjusted OR for the risk of RB was 1.36 (95% CI 0.85-2.16) (result not shown). The risk of RB increased with maternal age: adj OR ¼ 2.07, 95% CI (1.33-3.22) for women aged 35-39 years and adj OR ¼ 2.42 (1.22-4.81) for those aged 40 and above; it also increased with smoking before pregnancy. The risk of RB did not differ between IVF and the other infertility treatments (Table IV) .
After adjusting for maternal age and tobacco use, the risk of RB among women who had no infertility treatment increased significantly when time to pregnancy exceeded 24 months (adj OR ¼ 2.02, 95% CI 1.17 -3.48) ( Table V) . After controlling for time to pregnancy, the risk remained significantly higher in older women (Table V) .
Adjusting for level of maternal education did not modify the ORs for infertility treatment (adj OR ¼ 1.34, 95% CI 0.84 -2.16) for all RB non-familial cases. Nor were the adjusted ORs modified when we considered women who did not respond to questions about infertility treatments in the reference population as untreated [1.38 (0.87-2.20) ] for all RB non-familial cases.
Discussion
Our study did not find a significantly increased risk of RB in case of infertility treatment, regardless of the type of treatment (IVF, IUI or ovarian stimulation). We found an increased risk of RB for women whose time to pregnancy exceeded 24 months. The risk of RB was not associated with paternal age but did increase with maternal age.
An advantage to our work compared with previous studies is that it allowed us to study the role of ART in general, including treatments other than IVF, and to assess the impact of the underlying subfertility by analysing the time to pregnancy. These factors were studied while simultaneously taking other relevant variables into account.
Another advantage is the study power: based on the size of the sample of RB cases and of the reference population, with a frequency of infertility treatment of 6% in the reference population, the power to detect a doubled risk of RB in women with infertility treatment was around 95%, and around 60% for a risk multiplied by 1.5.
We used the data of the main reference centre for both diagnosis and treatment of RB in France. To assess the coverage of our sample, we compared these cases with those listed in the French national registry of children's cancers (RNTSE). During the 7-year study period (2000 -2006) , we registered 327 newly diagnosed children living in France compared with 349 children in the RNTSE, i.e. 93% of the population of children diagnosed with RB in France during that period. The regional distribution of our population did not differ from that of the registry, as no region was over-or under-represented.
Our response rate was excellent, with 92% of the families completing the questionnaire. Moreover, non-respondents and respondents did not differ for a variety of indirect indicators of infertility treatment, such as maternal age and type of pregnancy. These findings indicate that there was no major selection bias linked to the use or absence of infertility treatment.
Information on infertility treatment was collected by questionnaire after diagnosis in the RB group, while in the reference group it came from interviews conducted within days of birth. The differences in time elapsed since birth and method of data collection between the two groups may have induced differences in memory and answers; however, this is difficult to assess.
The inclusions in each group (index cases and national samples) do not cover exactly the same years of birth. While children in the national samples were born in 1998 or 2003, the index cases were aged between 0 and 5 years during the study period (2000) (2001) (2002) (2003) (2004) (2005) (2006) meaning that they were born between 1995 and 2006. Over this longer period of time, there may have been changes in the distribution of infertility treatments and maternal age. Information on infertility treatment was missing for 1403 women in the reference group. Classifying them as untreated did not change the results.
We studied all cases of non-familial forms. The exclusion of familial forms was justified by the presence of the RB1 mutation before pregnancy and the well-known and documented transmission mechanisms. We separated the subgroup including bilateral and unilateral multifocal forms, for whom we considered that the genetic mutation was present, and hypothesized that infertility treatments might have played a role in the germline mutation. The unilateral unifocal subgroup was the most heterogeneous: germline mutations are rare in this group and thus we considered it was the most relevant group for assessing the role of other risk factors, such as subfertility or infertility treatments. This was even more so for those with no mutation identified. However, no difference was found, but the smaller size of this subgroup reduced the power of this analysis. Maternal age was associated with an increased risk of RB. This result is consistent with several studies that have shown an increased incidence of childhood cancer in children of older mothers (Tarin et al., 1998; Magnani et al., 2003; Yip et al., 2006) , including for RB (Moll et al., 1996) . Older maternal age is also associated with other unfavourable outcomes such as declining fertility, chromosomal abnormalities, miscarriage, stillbirth and more recently retinopathy of prematurity (Wu, 2010) . Among the various hypotheses suggested is the possibility that subfertility rather than maternal age itself would be a risk factor for RB, given the role of maternal age in subfertility or infertility. But our results show increased risks of RB for both time to pregnancy and maternal age, each controlled for the other, suggesting two partly independent mechanisms. Paternal age has been identified as a risk factor for some childhood cancers, including leukaemia and central nervous system cancers (Yip et al., 2006) . We did not find any association between paternal age and RB, however. Not only is tobacco consumption a known risk factor of infertility, but parental smoking has also been associated with childhood cancer, particularly malignant central nervous system tumours (Plichart et al., 2008) . We found that the risk of RB increased significantly with smoking before pregnancy, but not during pregnancy. However, we were not able to determine exactly when the mothers had stopped smoking, e.g. before or just before conception or once they knew they were pregnant. Moreover, we did not record the number of cigarettes smoked. Our results are therefore difficult to interpret.
Finally, in the case of children conceived with the assistance of ART, high multiple pregnancy rates continue to be the most important factor adversely affecting outcome (Andersen, 2008) through the resulting increased risk of preterm delivery, low birthweight and perinatal mortality. One study found that infants with congenital heart defects were found more likely to have been conceived following ART, with rates varying according to the ART method (Tararbit et al., 2011) . More generally, however, the studies investigating physical health, growth, neurodevelopmental outcome and psychosocial development of children born after IVF, including with ICSI, have been reassuring, (Sutcliffe and Ludwig, 2007; Sutcliffe, 2008, 2011) .
Our results about children conceived by IVF are consistent with other IVF-register-based studies (Bradbury and Jick, 2004; Lidegaard et al., 2005) , which have not shown an increased risk of RB after IVF. However, the power of these studies was low. The most disturbing results came from Moll et al. (2003) Their results for IVF are thus consistent with ours for a similar period (adj OR ¼ 1.37, 95% CI 0.64 -2.97). Moreover, our results for infertility treatments other than IVF were the same (adj OR ¼ 1.35, 95% CI 0.77 -2.30). The latter results, however, and our finding of an increased risk of RB in women with long time to pregnancy are difficult to compare with other studies, precisely because our study is the first to consider these factors.
In conclusion, our results are generally reassuring: we did not observe an increased risk of RB associated with IVF or other types of ART and, to our knowledge, our study is the most powerful of the literature. We cannot totally rule out the possibility of an increased risk of RB, but if this increase exists, it is probably very low. More than the techniques themselves, it may be the underlying causes and context of subfertility/infertility that might engender unfavourable outcomes, including RB. Owing to missing data, the adjusted logistic model is based on 217 cases and 11 472 children in the national reference sample.
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